washington top u.s. lawmaker accuse food drug administration friday fail hand document would show whether criminal office fulfil critical mission protect public health fda long-overdue response leave key question unanswered performance effectiveness fda office criminal investigations house representatives energy commerce committee chairman greg walden tell reuters statement fda spokeswoman immediate comment walden comment come four months congressional panel launch examination criminal office manage case involve food drug devices review come reuters report fda agents concern managers include former oci director george karavetsos force pursue often toothless case involve mislabeled foreign-imported injectable drug expense case potential protect public health agents say become botox police spend hours chase doctor purchase authentic versions allergan popular anti-wrinkle drug label use countries concern come time office see half open case ultimately get close without action reuters find reuters also report fda permit karavetsos relocate back florida mid-2016 run oci miami office even fda already pay 25,000 move maryland 2015. fda meet committee october deadline provide write answer question jan. 19. next day karavetsos depart work dla piper represent drug device industry clients letter review reuters fda list investigative priorities say traditional metrics use gauge success arrest convictions capture impact public health mission also provide annual data arrest convictions number open case however omit preliminary-stage investigative number total number case open year make conviction rate appear high accord side-by-side comparison walden say fda provide performance plan among things also complain redactions separate record accord committee aide contain salary compensation information karavetsos house lawmaker seek document fda criminal office inquiry